南京中医药大学附属医院
纸质出版:2014
移动端阅览
[1]田永立,夏宁俊,李烜,刘沈林.中西医结合临床路径方案治疗胃癌患者100例临床观察[J].中医杂志,2014,55(22):1921-1925.
TIAN Yongli, XIA Ningjun, LI Xuan, et al. Clinical Observation on Integrative Medical Pathway for 100 Cases of Gastric Cancer[J]. Journal of Traditional Chinese Medicine2014, 55(22): 1921-1925.
[1]田永立,夏宁俊,李烜,刘沈林.中西医结合临床路径方案治疗胃癌患者100例临床观察[J].中医杂志,2014,55(22):1921-1925. DOI: 10.13288/j.11-2166/r.2014.22.010.
TIAN Yongli, XIA Ningjun, LI Xuan, et al. Clinical Observation on Integrative Medical Pathway for 100 Cases of Gastric Cancer[J]. Journal of Traditional Chinese Medicine2014, 55(22): 1921-1925. DOI: 10.13288/j.11-2166/r.2014.22.010.
目的观察胃癌中西医结合临床路径的临床疗效。方法将200例胃癌患者随机分为路径组和对照组各100例。路径组按照国家中医药管理局颁布的《胃癌中医临床路径》结合本院实际所形成的胃癌中西医结合临床路径进行治疗
具体包括中医辨证论治、辨证选用中成药、西医治疗
并根据情况选择中医特色疗法。对照组中有化疗指征者根据《胃癌NCCN指南(中国版)》选择方案化疗
同时采用制酸护胃、增强免疫力、营养支持、维持水电解质平衡等治疗
出现化疗副作用的常规对症处理。无化疗指征者予以最佳支持治疗。出现胃癌相关并发症者
给予对症处理。两组疗程为整个住院周期。治疗结束后评价两组患者住院天数、医疗费用、生活质量(QOL)评分和中医症状积分。结果路径组的住院天数明显低于对照组(P<0.05)
但医疗费用无明显下降(P>0.05)
路径组QOL评分和中医症状改善均明显优于对照组(P<0.05)。两组患者中医症状积分疗效的比较:路径组显效27例
有效54例
无效19例
总有效率81%;对照组显效15例
有效48例
无效37例
总有效率63%。两组总有效率比较差异均有统计学意义(P<0.01)
路径组优于对照组。结论实施胃癌中西医结合临床路径具有减少住院天数、改善中医证候、提高生活质量等优势。
Objective To observe the efficacy of integrative medical pathway in treating gastric cancer.Methods Totally 200 gastric cancer patients were randomized into the pathway group and control group
with 100 in each. In the pathway group
treatment combining with Traditional Chinese Medicine( TCM) Clinical Pathway for Gastric Cancer by the State Administration of Traditional Chinese Medicine and an integrative clinical pathway by the authors’ hospital was adopted
which included TCM syndrome differentiation to choose Chinese patent medicine and western medicine and using characteristic TCM therapies according to disease conditions. For patients with chemotherapy indications in the control group
the appropriate chemotherapy was chosen according to Gastric Cancer NCCN Guidelines( China). At the same time
the treatment of protecting the stomach with antacids
enhancing immunity
nutritional support
maintaining water and electrolyte balance was applied. Routine treatment was given to patients with side effects of chemotherapy. Patients without chemotherapy indications received supportive treatment. Patients with gastric cancer related complications received symptomatic treatment. The treatment courses of both groups were the whole hospitalization period. After treatment
the scores of hospital stays
medical costs
quality of life( QOL)and TCM symptom scores were assessed in both groups. Results The hospital stays in pathway group was significantly shorter than that in the control group( P < 0. 05)
but with no obvious decrease of medical cost( P > 0. 05).Comparing with the control group
the QOL score and TCM symptoms were significantly improved in pathway group( P <0.05). As for TCM symptom scores
there were 27 cases of markedly effectiveness
54 cases of effectiveness and 19 cases of ineffectiveness in the pathway group and the total effective rate was 81%
while 15 cases of markedly effectiveness
48 cases of effectiveness and 37 cases of ineffectiveness in the control group and the total effective rate was 63%. The difference between groups had statistical significance( P < 0. 01). Conclusion Integrative medical pathway can reduce hospital stays
relieve TCM symptoms and enhance QOL in patients with gastric cancer. But the pathway still needs to be further completed.
0
浏览量
509
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号